<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="mena-mig01/PMC4546629/results/search/mena-migration/results.xml">
  <result pre="of the Fertile Crescent region of the Middle East and" exact="North Africa" post="(MENA), namely Iraq, Jordan, Lebanon, Palestine, and Syria. Methods"/>
  <result pre="in Palestine (range: 0–9.0%; 95% CI: 0.2–0.3%), and 0.4% in" exact="Syria" post="(range: 0.3–0.9%; 95% CI: 0.4–0.5%). Among populations at high"/>
  <result pre="in Lebanon (range: 0–52.8%; 95% CI: 5.6–26.5%), and 47.4% in" exact="Syria" post="(range: 21.0–75.0%; 95% CI: 32.5–62.5%). Genotypes 4 and 1"/>
  <result pre="appears to be below 1%, lower than that in other" exact="MENA" post="sub-regions, and tending towards the lower end of the"/>
  <result pre="individuals [5]. In few countries of the Middle East and" exact="North Africa" post="(MENA) region, namely Egypt and Pakistan, HCV is prevalent"/>
  <result pre="[8, 9]. Meanwhile, infection levels remain poorly estimated for most" exact="MENA" post="countries including those in the Fertile Crescent (FC). Geographically,"/>
  <result pre="Geographically, for this study, we define the FC subregion of" exact="MENA" post="to include Iraq, Jordan, Lebanon, Palestine, and Syria. Since"/>
  <result pre="indirectly interlinked or affected by decades of political turmoil and" exact="refugee" post="waves within this territory. Our study primarily aims at"/>
  <result pre="diversity. This work is conducted under the umbrella of the" exact="MENA" post="HCV Epidemiology Synthesis Project; an ongoing effort to characterize"/>
  <result pre="inform key public health research, policy, and programming priorities in" exact="MENA" post="[7, 10–15]. Materials and Methods Data sources and search"/>
  <result pre="measures for countries in the Horn of Africa subregion of" exact="MENA" post="[10, 17]. Our search criteria can be found in"/>
  <result pre="2014), and country-level and international organizations’ reports available through the" exact="MENA" post="HIV/AIDS Epidemiology Synthesis Project database (up to April 23,"/>
  <result pre="2010 Different localities RDS People who inject drugs 199 45.2%" exact="Syria" post="(n = 5) Abdulkarim, 98 [92] Dialysis unit Convenience"/>
  <result pre="Othman, 01 [170] 1996 Hospital Convenience Hemodialysis patients 139 48.9%" exact="MENA" post="HIV/AIDS ESP, Middle East and North Africa HIV/AIDS Epidemiology"/>
  <result pre="Hemodialysis patients 139 48.9% MENA HIV/AIDS ESP, Middle East and" exact="North Africa" post="HIV/AIDS Epidemiology Synthesis Project database; MOH, Ministry of Health;"/>
  <result pre="14 [33] 2013 National blood bank Blood donors 9643 0.3%" exact="MENA" post="HIV ESP, 11 [18, 32] 2011 Blood donors 63477"/>
  <result pre="Shemer-Avni, 98 [90] Hospital SRS Outpatient hospital attendees 124 9%" exact="Syria" post="(n = 10) Ali, 10 [200] 2000–07 Blood trans"/>
  <result pre="[200] 2000–07 Blood trans center Convenience Blood donors 131403 0.4%" exact="MENA" post="HIV ESP, 10 [18, 32] Q 1, 2006 Blood"/>
  <result pre="10 [18, 32] Q 1, 2006 Blood donors 55549 0.3%" exact="MENA" post="HIV ESP, 10 [18, 32] Q 2, 2006 Blood"/>
  <result pre="10 [18, 32] Q 2, 2006 Blood donors 87920 0.4%" exact="MENA" post="HIV ESP, 10 [18, 32] Q 3, 2006 Blood"/>
  <result pre="10 [18, 32] Q 3, 2006 Blood donors 77734 0.6%" exact="MENA" post="HIV ESP, 10 [18, 32] Q 4, 2006 Blood"/>
  <result pre="10 [18, 32] Q 4, 2006 Blood donors 83347 0.5%" exact="MENA" post="HIV ESP, 10 [18, 32] Q 1, 2007 Blood"/>
  <result pre="10 [18, 32] Q 1, 2007 Blood donors 83501 0.4%" exact="MENA" post="HIV ESP, 10 [18, 32] Q 2, 2007 Blood"/>
  <result pre="10 [18, 32] Q 2, 2007 Blood donors 92452 0.4%" exact="MENA" post="HIV ESP, 10 [18, 32] Q 3, 2007 Blood"/>
  <result pre="10 [18, 32] Q 3, 2007 Blood donors 83560 0.5%" exact="MENA" post="HIV ESP, 10 [18, 32] 2011 Blood donors 416984"/>
  <result pre="416984 0.6% Othman, 02 [97] Convenience Blood donors 2100 0.9%" exact="MENA" post="HIV ESP, Middle East and North Africa HIV/AIDS Epidemiology"/>
  <result pre="Blood donors 2100 0.9% MENA HIV ESP, Middle East and" exact="North Africa" post="HIV/AIDS Epidemiology Synthesis Project database; PHIC, Palestinian Health Information"/>
  <result pre="0 Special clinical populations 0 Mixed populations 12 53363 0.3–4.9" exact="Syria" post="General population 17 1114550 0.3–0.9 0.4 0.4–0.5 216.6 (p&amp;lt;0.0001)"/>
  <result pre="countries of the Fertile Crescent. Country Iraq Jordan Lebanon Palestine" exact="Syria" post="n (%) n (%) n (%) n (%) n"/>
  <result pre="prevalence measures from country-level data were also identified through the" exact="MENA" post="HIV/AIDS Epidemiology Synthesis Project database [18, 32–38]. To sum,"/>
  <result pre="[90, 91] and at 9% among outpatient hospital attendees [90]." exact="Syria" post="Among populations at high risk (Table 2), high HCV"/>
  <result pre="of genotype 1 cases. The distribution of HCV genotypes in" exact="Syria" post="(S6E Fig) revealed genotype 4 as the most common"/>
  <result pre="5). The next most diverse genotype distributions were found in" exact="Syria" post="(H = 1.00 out of 1.95 or 51.8%), and"/>
  <result pre="subregion appears to have the lowest HCV prevalence of all" exact="MENA" post="subregions [7, 11–15]—substantially lower than in other MENA countries"/>
  <result pre="of all MENA subregions [7, 11–15]—substantially lower than in other" exact="MENA" post="countries namely Egypt [6, 7] and Pakistan [8, 9]."/>
  <result pre="versus 0.3%). Sensitivity analyses were not possible for Palestine and" exact="Syria" post="due to the small number of studies among other"/>
  <result pre="as hijama, is a common practice by community healers in" exact="MENA" post="[18, 126]. There is also evidence elsewhere in MENA"/>
  <result pre="in MENA [18, 126]. There is also evidence elsewhere in" exact="MENA" post="of a wider scope of community related HCV exposures"/>
  <result pre="among the adult population in FC ranges between 0.07% in" exact="Syria" post="and 0.35% in Palestine [136]. The population proportion of"/>
  <result pre="Palestine [136]. The population proportion of injecting drug use in" exact="MENA" post="as a whole is estimated at 0.24%; in the"/>
  <result pre="71, 89]. These showed HCV prevalence varying between 21% in" exact="Syria" post="and 52.8% in Lebanon (Table 2). Relatively low HCV"/>
  <result pre="FC seems thus somewhat lower than that observed in other" exact="MENA" post="countries and globally [23, 136]. With these overall limited"/>
  <result pre="of HCV incidence and prevalence in FC. Migration dynamics within" exact="MENA" post="may have played a role in HCV epidemiology in"/>
  <result pre="highly prevalent genotype in FC (Table 5). Genotype 4 in" exact="MENA" post="appears to have a larger frequency in countries geographically"/>
  <result pre="in this country—such as during the era of the Iraq-Iran" exact="war" post="[139–141]. Movement of Egyptian labor, who often came from"/>
  <result pre="to HCV incidence and prevalence remains poorly understood. Lebanon and" exact="Syria" post="showed higher genotype diversity with genotype 5 only detected"/>
  <result pre="better understanding of the epidemiology of this infection in this" exact="MENA" post="subregion. Elucidation of the role of key populations in"/>
  <result pre="national survey appealing for effective prevention and control measures. Eastern" exact="Mediterranean" post="health journal = La revue de sante de la"/>
  <result pre="the Horn of Africa sub-region of the Middle East and" exact="North Africa." post="Systematic reviews. 2014;3:146 Epub 2014/12/18. 10.1186/2046-4053-3-14625516265 11Mohamoud YA, Riome"/>
  <result pre="The Horn of Africa sub-region of the Middle East and" exact="North Africa." post="2014. Available at: http://www.crd.york.ac.uk/NIHR_PROSPERO/display_record.asp?ID=CRD42014010318#.VRpKHuEQuCd 2014. 18Abu-RaddadL, AkalaFA, SeminiI, RiednerG,"/>
  <result pre="et al.Epidemiology of HIV infection in the Middle East and" exact="North Africa." post="AIDS (London, England). 2010;24Suppl 2:S5–23. 10.1097/01.aids.0000386729.56683.33 .20610949 20ChooQL, KuoG,"/>
  <result pre="statistical computing. Vienna, Austria2014. 32Additional country-level data provided through the" exact="MENA" post="HIV/AIDS Epidemiology Synthesis Project database by the World Health"/>
  <result pre="BatienehA, et al.Epidemiology and cost of haemodialysis in Jordan. Eastern" exact="Mediterranean" post="Health Journal. 2007;13(3):654–63. .17687839 40Al-RubaieH. MH., MalikA.S. Seroconversion rate"/>
  <result pre="C virus specific antibodies among Iraqi children with thalassaemia. Eastern" exact="Mediterranean" post="health journal = La revue de sante de la"/>
  <result pre="Hepatitis B and C seroprevalence in the Lebanese population. Eastern" exact="Mediterranean" post="health journal = La revue de sante de la"/>
  <result pre="patients in Damascus, Syria. Infection. 2001;29(5):262–5. Epub 2001/11/02. .11688903 95collab:" exact="Syria" post="Mental Health Directorate and National AIDS Programme (of Syrian"/>
  <result pre="for hepatitis C virus infection in pregnant Iraqi women. Eastern" exact="Mediterranean" post="health journal = La revue de sante de la"/>
  <result pre="CarrozziniF, BarbutiS, QuartoM. Prevalence rates of viral hepatitis infections in" exact="refugee" post="Kurds from Iraq and Turkey. Infection. 2003;31(2):70–4. Epub 2003/04/12."/>
  <result pre="Prevalence of HCV/HIV co-infection among haemophilia patients in Baghdad. Eastern" exact="Mediterranean" post="health journal = La revue de sante de la"/>
  <result pre="Epub 2008/03/19. 10.1017/s095026880800054x .18346288 120KaradatA. Hepatitis C genotypes in Syrian" exact="refugee" post="patient in Turkey. Hepatology International. 2015;9(1 SUPPL. 1):S27610.1007/s12072-015-9609-1. ."/>
 </snippets>
</snippetsTree>
